Quote
—
—
No scored catalysts in the window yet.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
https://www.wsj.com/business/earnings/bud-brewer-ab-inbev-confident-on-full-year-results-as-volumes-earnings-pick-up-pace-a478b3a1 · 7/30/2026+0.60
https://www.proactiveinvestors.com/companies/news/1095460/ftse-100-live-london-index-opens-in-red-as-miners-fall-but-barratt-redrow-rallies-1095460.html · 7/15/2026-0.50
https://www.reuters.com/legal/government/pesticide-makers-stack-wins-against-us-environmental-public-health-groups-2026-07-13/ · 7/13/2026+0.80
https://www.wsj.com/health/healthcare/apollo-to-buy-3-4-billion-stake-in-bayer-contraceptives-business-be19939e · 7/10/2026+0.30
https://www.reuters.com/legal/litigation/bayer-gets-3-billion-apollo-deal-contraceptives-unit-2026-07-10/ · 7/10/2026+0.60
https://www.reuters.com/business/environment/bayer-hopes-speed-up-biofuel-feedstock-plan-amid-iran-war-energy-crunch-2026-06-10/ · 6/10/2026+0.40
https://www.globenewswire.com/news-release/2026/06/10/3309465/0/en/Nxera-Joins-OpenFold-AI-Research-Consortium-Alongside-Leading-Global-Pharmaceutical-and-AI-Companies-to-Accelerate-AI-enabled-Drug-Discovery.html · 6/10/2026+0.00
https://www.prnewswire.com/news-releases/costa-rica-hat-seine-bemuhungen-zur-investitionsforderung-in-europa-in-den-bereichen-agrartechnologie-globale-dienstleistungen-und-tourismusinfrastruktur-verstarkt-302780500.html · 5/22/2026+0.00
https://www.prnewswire.com/news-releases/costa-rica-strengthened-investment-promotion-efforts-in-europe-across-agritech-global-services-and-tourism-infrastructure-302780286.html · 5/22/2026+0.00
https://www.reuters.com/business/bayer-q1-operating-profit-up-9-crop-protection-unit-gains-2026-05-12/ · 5/12/2026+0.60
https://www.businesswire.com/news/home/20260506284405/en/Investigational-PET-Tracer-Iodine-124-Evuzamitide-from-Bayer-Met-Primary-Endpoints-in-Phase-III-Study-in-Patients-Suspected-to-Have-Cardiac-Amyloidosis/ · 5/7/2026+0.80
https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-says-its-experimental-blood-thinner-cuts-risk-severity-repeat-strokes-2026-05-06/ · 5/6/2026+0.80
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
